The key details to know:
1. Dexycu replaces long-dose steroid eye drops which can require patients to administer them four times a day and titrating down over four weeks, which can lead to low compliance.
2. Dexycu’s launch will be phased, with cataract surgery experts included in the initial phase ahead of the release to the wider ophthalmology community.
3. CMS released an updated reimbursement J-code for Dexycu, J1095, through the Healthcare Common Procedure Coding System.
More articles on supply chain:
ASC supply chain tip of the day: Leverage market share & volume
Are you a materials manager or managed by your materials?
Olio raises $2.5M to expand post-acute collaboration platform — 3 insights
